Development assistance for health (DAH) from international donors often focuses on specific diseases (HIV, malaria, tuberculosis) rather than strengthening the overall health system. What is the economic critique of this approach?
Think about your answer, then reveal below.
Model answer: Vertical (disease-specific) funding can distort national health priorities by directing resources toward donor-favored diseases rather than the country's most pressing health needs. It creates parallel systems (separate supply chains, staff, data systems) that duplicate government infrastructure. It can draw health workers away from primary care into better-funded vertical programs (internal brain drain). And it creates dependency — when donor funding ends, the vertical programs collapse because they were never integrated into the domestic health system. Horizontal (health system strengthening) approaches build sustainable capacity but are harder to measure and less attractive to donors seeking attributable results.
The tension between vertical and horizontal funding reflects a deeper economic tradeoff: vertical programs produce measurable, attributable results (number of bed nets distributed, people on antiretrovirals) that satisfy donor accountability requirements, while horizontal investments (training health workers, building supply chains, strengthening governance) produce diffuse, long-term benefits that are harder to attribute to any single donor. Both are necessary, and the optimal mix depends on the country's existing system capacity.